Survey of drug storage practice in homes, hospitals and patent medicine stores in Nsukka, Nigeria

Scientific Research and Essays

Volumn 4, Issue 11, 2009, Pages 1354-1359

  Obitte, N C ^a   Chukwu, A ^a   Odimegwu, D C ^b   Nwoke, V C ^c  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b UNIVERSITY OF PORT HARCOURT   (Nigeria)

^c NONE

Author keywords

Degradation; Drug storage; Microbial; Patent medicine stores; Stability

Indexed keywords

EID: 77952175877     PISSN: None     EISSN: 19922248     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Arinola A (2005). Nigeria's Health Insurance scheme (cover story). Nig. J. Pharm. 37: 7-8.
2. British Pharmacopoeia (BP) (2004). The Stationery Office, UK. (3): 2499.
3. Dodo ANO, Hayibor S (2002). Medicine safety in West Africa, West Afr. J. Pharm. 16(1): 1-4.
4. Eke FU, Frank-Briggs A, Ottor (2001).Childhood mortality in Port Harcourt, Nigeria. Ani Aggrawal's internet J. Forensic Med.Toxicol. 2: 3.
5. Fairn JW, Liebmann JA, Rowan MG (2005).The stability of cannabis and its preparations on storage. J. Pharm. Pharm. 28: 1-7.
6. Florence AT, Attwood D (1981). Physicochemical Principles of Pharmacy. London: The Macmillan press Ltd. pp. 445-446.
7. Kenneth AC, Gordon LA, Valentino JS (1986). Chemical Stability of Pharmaceuticals. 2nd ed. USA: John Willy and Sons Inc. 1: 1.
8. Mendie UE, Sylva BO, Oshoba EB, Brown SA (2005). Effects of microbial contamination of liquid multivitamin preparations. Nig. J. Pharm. 37: 37-40.
9. Narayanaswami K, Golani HC, Bami HL, Dua RD (1978). Stability of Cannabis sativa L. samples and their extracts, on prolonged storage in Delhi. UNODC-Bulletin on Narcotics. (4-006): 57-69.
10. Richard AR, Allen RT, Lynda M, Jeffrey CH, John MH (2005). Heat decreases Formoterol delivery. Chest. 128: 4036-4040.
11. Swarbrick J, Boylan CJ (2002). Encyclopaedia of Pharmaceutical Technology. 2nd Edn. Swarbrick J, Boylan CJ. (Eds). USA: Marcel Dekker Inc.; 2: 213, 214, 1678.
12. The Uppsala Monitoring Centre, WHO collaborating Centre for Inter-national Drug Monitoring (2000). Safety monitoring of medicinal products. Guidelines for setting up and running a pharmacovigilance centre.